Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. (ARTV) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 63 transactions totaling $165.3M, demonstrating a bullish sentiment with $164.7M in net insider flow. The most recent transaction on Feb 18, 2026 involved a transaction of 27,500 shares valued at $0.
ARTV Insider Activity Summary
Who Is Buying ARTV Stock?
No significant insider buying has been recorded for ARTV in the recent period.
Who Is Selling ARTV Stock?
No significant insider selling has been recorded for ARTV in the recent period.
Is Artiva Biotherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARTV is bullish with an Insider Alignment Score of 100/100 and a net flow of $164.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARTV Frequently Asked Questions
Understanding ARTV Insider Activity
Insider trading at Artiva Biotherapeutics, Inc. (ARTV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ARTV stock, having executed 63 transactions in the past 90 days. The most active insider is Peter Kolchinsky (Executive), who has made 7 transactions totaling $104.7M.
Related Tools
Track Artiva Biotherapeutics, Inc. Insider Activity
Get notified when executives and directors at ARTV file new Form 4 transactions